Products

Home > Products > API Active Pharmaceutical Ingredient > CAS 2212020-52-3,Orforg+lipron GLP-1RA Off-white to Light Yellow Powder with Molecular Formula C48H48F2N10O5 for T2DM and Obesity Management

Catagories

API Active Pharmaceutical Ingredient

(1209)

CDMO Service

(1)

Contacts

Contacts: Mr. Errol Zhou

Tel: 86-551-65523315

Fax: 86-551-65523375

Contact Now

Mail Us

CAS 2212020-52-3,Orforg+lipron GLP-1RA Off-white to Light Yellow Powder with Molecular Formula C48H48F2N10O5 for T2DM and Obesity Management

Name: CAS 2212020-52-3,Orforg+lipron GLP-1RA Off-white to Light Yellow Powder with Molecular Formula C48H48F2N10O5 for T2DM and Obesity Management
Brand: Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
SKU: 2212020-52-3
Availability: InStock

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO

Model Number: 2212020-52-3

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 working days

Payment Terms: L/C,D/A,T/T,Western Union,D/P

Supply Ability: 500kg

Get Best Price

Product Details

Product Description

Highlight:

CAS No::	2212020-52-3	Appearance::	Off-white To Light Yellow Powder
Molecular Formula::	C48H48F2N10O5	Molecular Weight::	882.97
EINECS NO::	960-735-6	MDL NO.::	N/A

CAS No::	2212020-52-3
Appearance::	Off-white To Light Yellow Powder
Molecular Formula::	C48H48F2N10O5
Molecular Weight::	882.97
EINECS NO::	960-735-6
MDL NO.::	N/A

CAS 2212020-52-3,Orforg+lipron GLP-1RA Off-white to Light Yellow Powder with Molecular Formula C48H48F2N10O5 for T2DM and Obesity Management

CAS 2212020-52-3

3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one

Product Description

Product Name: 3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one CAS 2212020-52-3

Synonyms

Orforg+lipron

Chemical & Physical Properties

Property	Specification
Appearance	Off-white to light yellow powder
Assay	NLT 99%
Density	1.50 g/cm³
Solubility	DMSO: 125 mg/mL (141.57 mM)

Application

Orforg+lipron is a non-peptide oral glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used in the management of type 2 diabetes mellitus (T2DM) and obesity.

Available Intermediates

Bromo-2,6-dimethylfluorobenzene CAS 99725-44-7
3-Aminobutanenitrile hcl CAS 1073666-54-2
1,3-diethyl 2-(4-bromophenyl)-4-hydroxy-4-methyl-6-oxocyclohexane-1,3-dicarboxylate CAS 4759-57-3
(S)-ethyl-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate CAS 2212021-77-5
(S)-1-(4-fluoro-1-methyl-1H-indazol-5-yl)-3-(2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-3-yl)-1H-imidazol-2(3H)-one hcl CAS 2212022-57-4
(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide CAS 1006381-03-8
4-Bromo-3-fluoro-2-methylaniline CAS 127408-03-1

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Tags:

API Active Pharmaceutical Ingredient

Pharmaceutical Intermediates

Chemical Intermediates

Coenzyme

Nucleotides

Peptides And Amino Acids

Fine Chemicals

Buffer Chemical

Cholic Acid Series

Pharmaceutical Excipients

Optoelectronic Materials

CDMO Service

CAS 2212020-52-3,Orforg+lipron GLP-1RA Off-white to Light Yellow Powder with Molecular Formula C48H48F2N10O5 for T2DM and Obesity Management

api in pharmaceutical industry,

active pharma ingredient,

api of pharmaceutical

Sevelamer Carbonate CAS 845273-93-0 API Ingredients C7H14CINO4

Fludrocortisone Acetate CAS 514-36-3 API Active Pharmaceutical Ingredient

CinnaMaldehyde Diethylacetal CAS 7148-78-9 API Active Pharmaceutical Ingredient Liquid

Odevixibat CAS 501692-44-0 API Active Pharmaceutical Ingredient Powder

Warfarin Sodium Clatharate CAS 67430-45-9 API Of Pharmaceutical

Lefamulin Acetate CAS 1350636-82-6 Active Pharma Ingredient C30H49NO7S

Voxelotor CAS 1446321-46-5 API Active Pharmaceutical Ingredient

Clindamycin Phosphate Powder CAS 24729-96-2 API In Pharmaceutical Industry

Ganciclovir CAS 82410-32-0 API Active Pharmaceutical Ingredient White Powder

Ascomycin / Immunomycin CAS 104987-12-4 Active Ingredient In Pharmaceutical

Eltrombopag CAS 496775-61-2 C25H22N4O4 Pharmaceutical Ingredients

API Active Pharmaceutical Ingredient

Pharmaceutical Intermediates

Chemical Intermediates

Coenzyme

Nucleotides

Peptides And Amino Acids

Fine Chemicals